Compare ONEW & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONEW | STRO |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.0M | 85.0M |
| IPO Year | 2020 | 2018 |
| Metric | ONEW | STRO |
|---|---|---|
| Price | $10.73 | $10.48 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 8 |
| Target Price | ★ $19.00 | $18.29 |
| AVG Volume (30 Days) | ★ 214.8K | 121.9K |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,872,334,000.00 | $105,646,000.00 |
| Revenue This Year | $2.33 | $63.08 |
| Revenue Next Year | $3.44 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.63 | N/A |
| 52 Week Low | $10.28 | $5.23 |
| 52 Week High | $21.00 | $21.50 |
| Indicator | ONEW | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 36.18 | 79.98 |
| Support Level | $10.29 | $8.49 |
| Resistance Level | $10.81 | $10.10 |
| Average True Range (ATR) | 0.55 | 1.02 |
| MACD | 0.03 | 0.11 |
| Stochastic Oscillator | 21.38 | 81.73 |
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.